课题基金 / 基金详情

POST-ENDOCYTOTIC INFLAMMATORY SIGNALING AFTER TRAUMA

POST-ENDOCYTOTIC INFLAMMATORY SIGNALING AFTER TRAUMA
创伤后内吞后炎症信号传导
批准号:
6919600
负责人:
ANIRBAN BANERJEE
金额:
$16.22万
依托单位国家:
美国
项目类别:
财政年份:
2005
资助国家:
美国
项目状态:
已结题
起止时间:
2005-07-01 至 2010-03-31

项目摘要

项目成果

ANIRBAN BANERJEE的其他基金

相似基金

相关文献

中文摘要
翻译
创伤性损伤包括休克、组织损伤、骨折和输血,释放循环因子(如TNFalpha、IL-1和IPS),促进全身高度炎症。这些药物立即激活循环白细胞、内皮细胞和血管细胞上的信号受体,从而启动或改变这些细胞类型及其随后的反应。信号传导的初始阶段由配体激活的受体从质膜表面开始,由第二信使、离子通量和在几分钟内发生的蛋白质磷酸化介导。激活的受体募集的衔接蛋白通常与钙离子和局部膜组成的变化相协调。一系列的组装事件形成了聚集的信号复合物,这些复合物构建了多结构域蛋白支架,同时进行内吞作用和
英文摘要
Traumatic injury involving shock, tissue injury, fracture and transfusion, releases circulating factors (such as TNFalpha, IL-1 and IPS) that promote systemic hyper-inflammation. These agents immediately activate signaling receptors on circulating leukocytes, endothelium and vascular cells, thereby priming or altering these cell-types, and their subsequent responses. The initial phase of signaling by ligand activated receptor from the plasma membrane surface, is mediated by second messengers, ion-fluxes, and protein phosphorylation occurring within minutes. Activated receptors recruit adaptor proteins often coordinated with change in Ca++ and local membrane composition. A series of assembly events forms clustered signaling complexes that build-up multi-domain protein scaffolds which simultaneously conduct endocytosis and activate kinase modules such as MAPKs and IKK. These modules cause many sustained changes to the transcriptome, thereby affecting all subsequent cellular responses for hours or days, including cell-cycling or apoptosis. In leukocytes, MAPK modules regulate pro-inflammatory actions: superoxide secretion, and degranulation in neutrophils, synthesis and release of cytokines and chemokines. In vascular endothelial and smooth muscle cells, NF-kB and AP-1 upregulate expression of leuko-adhesive proteins, promoting inflammation and leak. Cell biologists have known that that clathrin-mediated endocytosis (CME) can be blocked by hypertonicity and primary amines block (by affecting endosome assembly or disrupting its maturation). In several transformed cells, interfering with CME prevents MAPK or NF-kB signaling by bioactive mediators (such as catechols, lipids and TNFalpha). However, it is unclear how the different stages of CME processing regulates kinase signaling by internalized receptors in mammalian, especially human, cells. Further, would the results in primary cells reflect inflammatory signaling in animal models? Remarkably, advances in resuscitation suggest that hypertonicity has additional advantages for preventing pro-inflammatory priming. Separately, some primary amines and microtubule effectors appear promising for inflammation control. In this proposal we assess whether suppressing endocytosis affects postendocytotic signaling for a permuted list of culpable agents and cells. If so, could the mechanisms suggest improvements or alternatives?
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Project 3: Anti-Inflammatory Mechanisms of Inhaled Hypertonic Saline
  • 批准号:
    8382283
  • 项目类别:
  • 资助金额:
    $36.63万
  • 财政年份:
    2012
  • 负责人:
    ANIRBAN BANERJEE
  • 依托单位:
Trauma Primes Cells
  • 批准号:
    8069421
  • 项目类别:
  • 资助金额:
    $44.97万
  • 财政年份:
    2010
  • 负责人:
    ANIRBAN BANERJEE
  • 依托单位:
CORE--CELL AND IMAGING
  • 批准号:
    6973946
  • 项目类别:
  • 资助金额:
    $18.53万
  • 财政年份:
    2005
  • 负责人:
    ANIRBAN BANERJEE
  • 依托单位:
Administrative Core
  • 批准号:
    6919601
  • 项目类别:
  • 资助金额:
    $14.85万
  • 财政年份:
    2005
  • 负责人:
    ANIRBAN BANERJEE
  • 依托单位:
国内基金
海外基金
微量元素铁通过TfR1/Clathrin/Notch信号轴调控猪肠道黏膜屏障抵御PDCoV感染的机制研究
  • 批准号:
    32402729
  • 项目类别:
    青年科学基金项目
  • 资助金额:
    30.00万元
  • 批准年份:
    2024
  • 负责人:
    张帅
  • 依托单位:
通过Clathrin/AP2途径介导内皮细胞Occludin自噬性降解以靶向开放胶质瘤血肿瘤屏障的机制研究
  • 批准号:
    --
  • 项目类别:
    青年科学基金项目
  • 资助金额:
    30万元
  • 批准年份:
    2022
  • 负责人:
    艾潇琳
  • 依托单位:
GRB2/Clathrin/ESCRT介导的内吞、运输及溶酶体降解在CD7 CAR-T细胞诱导T细胞CD7阴性表达的机制研究
  • 批准号:
    82270234
  • 项目类别:
    面上项目
  • 资助金额:
    52万元
  • 批准年份:
    2022
  • 负责人:
    胡永仙
  • 依托单位:
通过Clathrin/AP2途径介导内皮细胞Occludin自噬性降解以靶向开放胶质瘤血肿瘤屏障的机制研究
  • 批准号:
    82202889
  • 项目类别:
    青年科学基金项目(C类)
  • 资助金额:
    30.0万元
  • 批准年份:
    2022
  • 负责人:
    艾潇琳
  • 依托单位: